Literature DB >> 20880065

Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease.

Motoh Iwasa1, Nagisa Hara, Kazuko Iwata, Masumi Ishidome, Ryosuke Sugimoto, Hideaki Tanaka, Naoki Fujita, Yoshinao Kobayashi, Yoshiyuki Takei.   

Abstract

AIM: To clarify the impact of visceral fat on chronic liver diseases such as non-alcoholic fatty liver disease (NAFLD) and hepatitis C, we investigated the effects of lifestyle modifications on the amount of visceral fat, liver biochemistry and serum ferritin levels in patients with liver disease.
METHODS: Eighty-two patients (NAFLD, n = 37; hepatitis C, n = 45) were advised to adopt lifestyle modifications, including dietary changes and exercise, and these were maintained for 6 months. Bodyweight, percentage of body fat, visceral fat area (VFA) and serum alanine aminotransferase (ALT) and ferritin were measured before and after intervention.
RESULTS: In NAFLD, the mean VFA of 134.5 cm(2) was significantly reduced to 125.3 cm(2) after 6 months (P < 0.001). ALT levels improved significantly between the values measured before and after intervention (P = 0.039). The VFA prior to intervention was 100 cm(2) in hepatitis C patients and it was reduced significantly after 6 months to 95.6 cm(2) (P < 0.001). ALT levels also improved significantly in the hepatitis C patients (P < 0.001). The serum ferritin levels also reduced in these patients. Improvements in serum ALT and ferritin levels correlated with the amount of visceral fat reduction in both groups (P = 0.046, P = 0.008, respectively).
CONCLUSION: These findings demonstrate that restriction of calorie and iron intake results in reduction of visceral fat, liver enzymes and ferritin in patients with chronic liver disease. Visceral fat may be a central target for future interventions, not only in NAFLD but also in hepatitis C.
© 2010 The Japan Society of Hepatology.

Entities:  

Year:  2010        PMID: 20880065     DOI: 10.1111/j.1872-034X.2010.00724.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  8 in total

1.  Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study.

Authors:  Takumi Kawaguchi; Naoto Shiba; Takashi Maeda; Toru Matsugaki; Yoshio Takano; Minoru Itou; Masahiro Sakata; Eitaro Taniguchi; Kensei Nagata; Michio Sata
Journal:  J Gastroenterol       Date:  2011-02-22       Impact factor: 7.527

2.  Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia.

Authors:  Yumeo Tateyama; Atsushi Naganuma; Yuhei Suzuki; Tomoyuki Masuda; Sanae Uehara; Takashi Hoshino; Hidetoshi Yasuoka; Tomohiro Kudo; Yusuke Ogawa; Tetsushi Ogawa; Kohei Tateno; Norihiro Ishii; Kenichiro Araki; Norifumi Harimoto; Ken Shirabe; Satoru Kakizaki
Journal:  Clin J Gastroenterol       Date:  2021-01-28

3.  Daumone fed late in life improves survival and reduces hepatic inflammation and fibrosis in mice.

Authors:  Jong Hee Park; Hae Young Chung; Minkyu Kim; Jung Hwa Lee; Mankil Jung; Hunjoo Ha
Journal:  Aging Cell       Date:  2014-05-06       Impact factor: 9.304

4.  Major components of metabolic syndrome and nutritional intakes in different genotype of UCP2 -866G/A gene polymorphisms in patients with NAFLD.

Authors:  Mahdieh Abbasalizad Farhangi; Fatemeh Mohseni; Safar Farajnia; Mohammad-Asghari Jafarabadi
Journal:  J Transl Med       Date:  2016-06-14       Impact factor: 5.531

5.  The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).

Authors:  Yoshinao Kobayashi; Nagisa Hara; Ryosuke Sugimoto; Rumi Mifuji-Moroka; Hideaki Tanaka; Akiko Eguchi; Motoh Iwasa; Hiroshi Hasegawa; Kazuko Iwata; Yoshiyuki Takei; Osamu Taguchi
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

6.  A Low Iron Diet Protects from Steatohepatitis in a Mouse Model.

Authors:  Lipika Salaye; Ielizaveta Bychkova; Sandy Sink; Alexander J Kovalic; Manish S Bharadwaj; Felipe Lorenzo; Shalini Jain; Alexandria V Harrison; Ashley T Davis; Katherine Turnbull; Nuwan T Meegalla; Soh-Hyun Lee; Robert Cooksey; George L Donati; Kylie Kavanagh; Herbert L Bonkovsky; Donald A McClain
Journal:  Nutrients       Date:  2019-09-10       Impact factor: 5.717

7.  Recombinant FGF21 Attenuates Polychlorinated Biphenyl-Induced NAFLD/NASH by Modulating Hepatic Lipocalin-2 Expression.

Authors:  Hye Young Kim; Young Hyun Yoo
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

Review 8.  Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).

Authors:  Mingmei Shao; Zixiang Ye; Yanhong Qin; Tao Wu
Journal:  Exp Ther Med       Date:  2020-08-28       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.